aluates Reports

$ 0.0

Automative

Global Artificial Intelligence Drug R&D Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-6E6123

Global Artificial Intelligence Drug R D Market Insights Forecast to 2028

BUY CHAPTERS

Global Artificial Intelligence Drug R&D Market Research Report 2025

Code: QYRE-Auto-6E6123

Report

July 2025

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

IBM Watson

BioXel

InSilico Medicine

Gatehouse Bio

Google DeepMind

Genpact Cora

Cyclica Inc

QuantumBlack

Nq Medical

Phenomic AI

Palantir Technologies

BenevolentAI

Atomwise

Numerate Inc

Recursion Pharmaceuticals

Exscientia Ltd

TwoXAR

AiCure

Artificial Intelligence Drug R&D Market Size

The global market for Artificial Intelligence Drug R&D was valued at US$ 710 million in the year 2024 and is projected to reach a revised size of US$ 1255 million by 2031, growing at a CAGR of 8.6% during the forecast period.

Artificial Intelligence Drug R&D Market

Artificial Intelligence Drug R&D means that we use AI (narrow AI for now, which specilizing in few tasks) to generate and analyse immense amounts of biological and outcomes data from patients or chem database to predict new targets, or to conclude standard models.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Drug R&D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Drug R&D.

The Artificial Intelligence Drug R&D market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Intelligence Drug R&D market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Artificial Intelligence Drug R&D companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Artificial Intelligence Drug R&D Market Report

Report Metric	Details
Report Name	Artificial Intelligence Drug R&D Market
Accounted market size in year	US$ 710 million
Forecasted market size in 2031	US$ 1255 million
CAGR	8.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	AI Platfrom Analytics Service
Segment by Application	Drug Discovery Precision Medicine
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	IBM Watson, BioXel, Insilico Medicine, Gatehouse Bio, Google DeepMind, Genpact Cora, Cyclica Inc, QuantumBlack, Nq Medical, Phenomic AI, Palantir Technologies, BenevolentAI, Atomwise, Numerate, Recursion Pharmaceuticals, Exscientia, TwoXAR, AiCure
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence Drug R&D company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Artificial Intelligence Drug R&D Market growing?

Ans: The Artificial Intelligence Drug R&D Market witnessing a CAGR of 8.6% during the forecast period 2025-2031.

What is the Artificial Intelligence Drug R&D Market size in 2031?

Ans: The Artificial Intelligence Drug R&D Market size in 2031 will be US$ 1255 million.

Who are the main players in the Artificial Intelligence Drug R&D Market report?

Ans: The main players in the Artificial Intelligence Drug R&D Market are IBM Watson, BioXel, Insilico Medicine, Gatehouse Bio, Google DeepMind, Genpact Cora, Cyclica Inc, QuantumBlack, Nq Medical, Phenomic AI, Palantir Technologies, BenevolentAI, Atomwise, Numerate, Recursion Pharmaceuticals, Exscientia, TwoXAR, AiCure

What are the Application segmentation covered in the Artificial Intelligence Drug R&D Market report?

Ans: The Applications covered in the Artificial Intelligence Drug R&D Market report are Drug Discovery, Precision Medicine

What are the Type segmentation covered in the Artificial Intelligence Drug R&D Market report?

Ans: The Types covered in the Artificial Intelligence Drug R&D Market report are AI Platfrom, Analytics Service

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 AI Platfrom

1.2.3 Analytics Service

1.3 Market by Application

1.3.1 Global Artificial Intelligence Drug R&D Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Drug Discovery

1.3.3 Precision Medicine

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Artificial Intelligence Drug R&D Market Perspective (2020-2031)

2.2 Global Artificial Intelligence Drug R&D Growth Trends by Region

2.2.1 Global Artificial Intelligence Drug R&D Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Artificial Intelligence Drug R&D Historic Market Size by Region (2020-2025)

2.2.3 Artificial Intelligence Drug R&D Forecasted Market Size by Region (2026-2031)

2.3 Artificial Intelligence Drug R&D Market Dynamics

2.3.1 Artificial Intelligence Drug R&D Industry Trends

2.3.2 Artificial Intelligence Drug R&D Market Drivers

2.3.3 Artificial Intelligence Drug R&D Market Challenges

2.3.4 Artificial Intelligence Drug R&D Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Artificial Intelligence Drug R&D Players by Revenue

3.1.1 Global Top Artificial Intelligence Drug R&D Players by Revenue (2020-2025)

3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2020-2025)

3.2 Global Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Artificial Intelligence Drug R&D Revenue

3.4 Global Artificial Intelligence Drug R&D Market Concentration Ratio

3.4.1 Global Artificial Intelligence Drug R&D Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug R&D Revenue in 2024

3.5 Global Key Players of Artificial Intelligence Drug R&D Head office and Area Served

3.6 Global Key Players of Artificial Intelligence Drug R&D, Product and Application

3.7 Global Key Players of Artificial Intelligence Drug R&D, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Artificial Intelligence Drug R&D Breakdown Data by Type

4.1 Global Artificial Intelligence Drug R&D Historic Market Size by Type (2020-2025)

4.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2026-2031)

5 Artificial Intelligence Drug R&D Breakdown Data by Application

5.1 Global Artificial Intelligence Drug R&D Historic Market Size by Application (2020-2025)

5.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Artificial Intelligence Drug R&D Market Size (2020-2031)

6.2 North America Artificial Intelligence Drug R&D Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Artificial Intelligence Drug R&D Market Size by Country (2020-2025)

6.4 North America Artificial Intelligence Drug R&D Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Artificial Intelligence Drug R&D Market Size (2020-2031)

7.2 Europe Artificial Intelligence Drug R&D Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Artificial Intelligence Drug R&D Market Size by Country (2020-2025)

7.4 Europe Artificial Intelligence Drug R&D Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size (2020-2031)

8.2 Asia-Pacific Artificial Intelligence Drug R&D Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2020-2025)

8.4 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Artificial Intelligence Drug R&D Market Size (2020-2031)

9.2 Latin America Artificial Intelligence Drug R&D Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Artificial Intelligence Drug R&D Market Size by Country (2020-2025)

9.4 Latin America Artificial Intelligence Drug R&D Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size (2020-2031)

10.2 Middle East & Africa Artificial Intelligence Drug R&D Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2020-2025)

10.4 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 IBM Watson

11.1.1 IBM Watson Company Details

11.1.2 IBM Watson Business Overview

11.1.3 IBM Watson Artificial Intelligence Drug R&D Introduction

11.1.4 IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.1.5 IBM Watson Recent Development

11.2 BioXel

11.2.1 BioXel Company Details

11.2.2 BioXel Business Overview

11.2.3 BioXel Artificial Intelligence Drug R&D Introduction

11.2.4 BioXel Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.2.5 BioXel Recent Development

11.3 Insilico Medicine

11.3.1 Insilico Medicine Company Details

11.3.2 Insilico Medicine Business Overview

11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Introduction

11.3.4 Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.3.5 Insilico Medicine Recent Development

11.4 Gatehouse Bio

11.4.1 Gatehouse Bio Company Details

11.4.2 Gatehouse Bio Business Overview

11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Introduction

11.4.4 Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.4.5 Gatehouse Bio Recent Development

11.5 Google DeepMind

11.5.1 Google DeepMind Company Details

11.5.2 Google DeepMind Business Overview

11.5.3 Google DeepMind Artificial Intelligence Drug R&D Introduction

11.5.4 Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.5.5 Google DeepMind Recent Development

11.6 Genpact Cora

11.6.1 Genpact Cora Company Details

11.6.2 Genpact Cora Business Overview

11.6.3 Genpact Cora Artificial Intelligence Drug R&D Introduction

11.6.4 Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.6.5 Genpact Cora Recent Development

11.7 Cyclica Inc

11.7.1 Cyclica Inc Company Details

11.7.2 Cyclica Inc Business Overview

11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Introduction

11.7.4 Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.7.5 Cyclica Inc Recent Development

11.8 QuantumBlack

11.8.1 QuantumBlack Company Details

11.8.2 QuantumBlack Business Overview

11.8.3 QuantumBlack Artificial Intelligence Drug R&D Introduction

11.8.4 QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.8.5 QuantumBlack Recent Development

11.9 Nq Medical

11.9.1 Nq Medical Company Details

11.9.2 Nq Medical Business Overview

11.9.3 Nq Medical Artificial Intelligence Drug R&D Introduction

11.9.4 Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.9.5 Nq Medical Recent Development

11.10 Phenomic AI

11.10.1 Phenomic AI Company Details

11.10.2 Phenomic AI Business Overview

11.10.3 Phenomic AI Artificial Intelligence Drug R&D Introduction

11.10.4 Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.10.5 Phenomic AI Recent Development

11.11 Palantir Technologies

11.11.1 Palantir Technologies Company Details

11.11.2 Palantir Technologies Business Overview

11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Introduction

11.11.4 Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.11.5 Palantir Technologies Recent Development

11.12 BenevolentAI

11.12.1 BenevolentAI Company Details

11.12.2 BenevolentAI Business Overview

11.12.3 BenevolentAI Artificial Intelligence Drug R&D Introduction

11.12.4 BenevolentAI Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.12.5 BenevolentAI Recent Development

11.13 Atomwise

11.13.1 Atomwise Company Details

11.13.2 Atomwise Business Overview

11.13.3 Atomwise Artificial Intelligence Drug R&D Introduction

11.13.4 Atomwise Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.13.5 Atomwise Recent Development

11.14 Numerate

11.14.1 Numerate Company Details

11.14.2 Numerate Business Overview

11.14.3 Numerate Artificial Intelligence Drug R&D Introduction

11.14.4 Numerate Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.14.5 Numerate Recent Development

11.15 Recursion Pharmaceuticals

11.15.1 Recursion Pharmaceuticals Company Details

11.15.2 Recursion Pharmaceuticals Business Overview

11.15.3 Recursion Pharmaceuticals Artificial Intelligence Drug R&D Introduction

11.15.4 Recursion Pharmaceuticals Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.15.5 Recursion Pharmaceuticals Recent Development

11.16 Exscientia

11.16.1 Exscientia Company Details

11.16.2 Exscientia Business Overview

11.16.3 Exscientia Artificial Intelligence Drug R&D Introduction

11.16.4 Exscientia Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.16.5 Exscientia Recent Development

11.17 TwoXAR

11.17.1 TwoXAR Company Details

11.17.2 TwoXAR Business Overview

11.17.3 TwoXAR Artificial Intelligence Drug R&D Introduction

11.17.4 TwoXAR Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.17.5 TwoXAR Recent Development

11.18 AiCure

11.18.1 AiCure Company Details

11.18.2 AiCure Business Overview

11.18.3 AiCure Artificial Intelligence Drug R&D Introduction

11.18.4 AiCure Revenue in Artificial Intelligence Drug R&D Business (2020-2025)

11.18.5 AiCure Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

IBM Watson

BioXel

InSilico Medicine

Gatehouse Bio

Google DeepMind

Genpact Cora

Cyclica Inc

QuantumBlack

Nq Medical

Phenomic AI

Palantir Technologies

BenevolentAI

Atomwise

Numerate Inc

Recursion Pharmaceuticals

Exscientia Ltd

TwoXAR

AiCure

List of Tables

Table 1. Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of AI Platfrom

Table 3. Key Players of Analytics Service

Table 4. Global Artificial Intelligence Drug R&D Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Artificial Intelligence Drug R&D Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Artificial Intelligence Drug R&D Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Artificial Intelligence Drug R&D Market Share by Region (2020-2025)

Table 8. Global Artificial Intelligence Drug R&D Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Artificial Intelligence Drug R&D Market Share by Region (2026-2031)

Table 10. Artificial Intelligence Drug R&D Market Trends

Table 11. Artificial Intelligence Drug R&D Market Drivers

Table 12. Artificial Intelligence Drug R&D Market Challenges

Table 13. Artificial Intelligence Drug R&D Market Restraints

Table 14. Global Artificial Intelligence Drug R&D Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Artificial Intelligence Drug R&D Market Share by Players (2020-2025)

Table 16. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug R&D as of 2024)

Table 17. Ranking of Global Top Artificial Intelligence Drug R&D Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Artificial Intelligence Drug R&D Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Artificial Intelligence Drug R&D, Headquarters and Area Served

Table 20. Global Key Players of Artificial Intelligence Drug R&D, Product and Application

Table 21. Global Key Players of Artificial Intelligence Drug R&D, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Artificial Intelligence Drug R&D Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2020-2025)

Table 25. Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2026-2031)

Table 27. Global Artificial Intelligence Drug R&D Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2020-2025)

Table 29. Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2026-2031)

Table 31. North America Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Artificial Intelligence Drug R&D Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Artificial Intelligence Drug R&D Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Artificial Intelligence Drug R&D Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Artificial Intelligence Drug R&D Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Artificial Intelligence Drug R&D Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Artificial Intelligence Drug R&D Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Artificial Intelligence Drug R&D Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2026-2031) & (US$ Million)

Table 46. IBM Watson Company Details

Table 47. IBM Watson Business Overview

Table 48. IBM Watson Artificial Intelligence Drug R&D Product

Table 49. IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 50. IBM Watson Recent Development

Table 51. BioXel Company Details

Table 52. BioXel Business Overview

Table 53. BioXel Artificial Intelligence Drug R&D Product

Table 54. BioXel Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 55. BioXel Recent Development

Table 56. Insilico Medicine Company Details

Table 57. Insilico Medicine Business Overview

Table 58. Insilico Medicine Artificial Intelligence Drug R&D Product

Table 59. Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 60. Insilico Medicine Recent Development

Table 61. Gatehouse Bio Company Details

Table 62. Gatehouse Bio Business Overview

Table 63. Gatehouse Bio Artificial Intelligence Drug R&D Product

Table 64. Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 65. Gatehouse Bio Recent Development

Table 66. Google DeepMind Company Details

Table 67. Google DeepMind Business Overview

Table 68. Google DeepMind Artificial Intelligence Drug R&D Product

Table 69. Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 70. Google DeepMind Recent Development

Table 71. Genpact Cora Company Details

Table 72. Genpact Cora Business Overview

Table 73. Genpact Cora Artificial Intelligence Drug R&D Product

Table 74. Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 75. Genpact Cora Recent Development

Table 76. Cyclica Inc Company Details

Table 77. Cyclica Inc Business Overview

Table 78. Cyclica Inc Artificial Intelligence Drug R&D Product

Table 79. Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 80. Cyclica Inc Recent Development

Table 81. QuantumBlack Company Details

Table 82. QuantumBlack Business Overview

Table 83. QuantumBlack Artificial Intelligence Drug R&D Product

Table 84. QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 85. QuantumBlack Recent Development

Table 86. Nq Medical Company Details

Table 87. Nq Medical Business Overview

Table 88. Nq Medical Artificial Intelligence Drug R&D Product

Table 89. Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 90. Nq Medical Recent Development

Table 91. Phenomic AI Company Details

Table 92. Phenomic AI Business Overview

Table 93. Phenomic AI Artificial Intelligence Drug R&D Product

Table 94. Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 95. Phenomic AI Recent Development

Table 96. Palantir Technologies Company Details

Table 97. Palantir Technologies Business Overview

Table 98. Palantir Technologies Artificial Intelligence Drug R&D Product

Table 99. Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 100. Palantir Technologies Recent Development

Table 101. BenevolentAI Company Details

Table 102. BenevolentAI Business Overview

Table 103. BenevolentAI Artificial Intelligence Drug R&D Product

Table 104. BenevolentAI Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 105. BenevolentAI Recent Development

Table 106. Atomwise Company Details

Table 107. Atomwise Business Overview

Table 108. Atomwise Artificial Intelligence Drug R&D Product

Table 109. Atomwise Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 110. Atomwise Recent Development

Table 111. Numerate Company Details

Table 112. Numerate Business Overview

Table 113. Numerate Artificial Intelligence Drug R&D Product

Table 114. Numerate Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 115. Numerate Recent Development

Table 116. Recursion Pharmaceuticals Company Details

Table 117. Recursion Pharmaceuticals Business Overview

Table 118. Recursion Pharmaceuticals Artificial Intelligence Drug R&D Product

Table 119. Recursion Pharmaceuticals Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 120. Recursion Pharmaceuticals Recent Development

Table 121. Exscientia Company Details

Table 122. Exscientia Business Overview

Table 123. Exscientia Artificial Intelligence Drug R&D Product

Table 124. Exscientia Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 125. Exscientia Recent Development

Table 126. TwoXAR Company Details

Table 127. TwoXAR Business Overview

Table 128. TwoXAR Artificial Intelligence Drug R&D Product

Table 129. TwoXAR Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 130. TwoXAR Recent Development

Table 131. AiCure Company Details

Table 132. AiCure Business Overview

Table 133. AiCure Artificial Intelligence Drug R&D Product

Table 134. AiCure Revenue in Artificial Intelligence Drug R&D Business (2020-2025) & (US$ Million)

Table 135. AiCure Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

Table 139. Authors List of This Report

List of Figures

Figure 1. Artificial Intelligence Drug R&D Picture

Figure 2. Global Artificial Intelligence Drug R&D Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Artificial Intelligence Drug R&D Market Share by Type: 2024 VS 2031

Figure 4. AI Platfrom Features

Figure 5. Analytics Service Features

Figure 6. Global Artificial Intelligence Drug R&D Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Artificial Intelligence Drug R&D Market Share by Application: 2024 VS 2031

Figure 8. Drug Discovery Case Studies

Figure 9. Precision Medicine Case Studies

Figure 10. Artificial Intelligence Drug R&D Report Years Considered

Figure 11. Global Artificial Intelligence Drug R&D Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Artificial Intelligence Drug R&D Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Artificial Intelligence Drug R&D Market Share by Region: 2024 VS 2031

Figure 14. Global Artificial Intelligence Drug R&D Market Share by Players in 2024

Figure 15. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug R&D as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Artificial Intelligence Drug R&D Revenue in 2024

Figure 17. North America Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Artificial Intelligence Drug R&D Market Share by Country (2020-2031)

Figure 19. United States Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Artificial Intelligence Drug R&D Market Share by Country (2020-2031)

Figure 23. Germany Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Artificial Intelligence Drug R&D Market Share by Region (2020-2031)

Figure 31. China Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Artificial Intelligence Drug R&D Market Share by Country (2020-2031)

Figure 39. Mexico Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Artificial Intelligence Drug R&D Market Share by Country (2020-2031)

Figure 43. Turkey Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Artificial Intelligence Drug R&D Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. IBM Watson Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 47. BioXel Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 48. Insilico Medicine Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 49. Gatehouse Bio Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 50. Google DeepMind Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 51. Genpact Cora Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 52. Cyclica Inc Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 53. QuantumBlack Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 54. Nq Medical Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 55. Phenomic AI Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 56. Palantir Technologies Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 57. BenevolentAI Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 58. Atomwise Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 59. Numerate Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 60. Recursion Pharmaceuticals Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 61. Exscientia Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 62. TwoXAR Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 63. AiCure Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Artificial Intelligence AI in Drug Discovery Market Insights Forecast to 2030

Global AI for Drug Discovery and Development Market Research Report 2025

Global AI Technology in Pharmaceutical Market Research Report 2024

AI driven Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Discovery AI Tools Market Research Report 2025

Global AI Drug Discovery Software Market Research Report 2024

Global Drug Developing Platforms by Artificial Intelligence AI Market Research Report 2024

Global Artificial Intelligence in Drug Discovery Market Size Status and Forecast 2020 2026

Global Artificial Intelligence Drug Development Market Research Report 2024

Artificial Intelligence For Drug Development and Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Assisted Drug Discovery Software Market Research Report 2024

Global Artificial Intelligence AI in Life Sciences Market Research Report 2024

Global AI based Clinical Trials Solution Provider Market Research Report 2024

Global AI In Clinical Trials Market Research Report 2024

Global Intelligent Clinical Trials Market Research Report 2024

Global Commerce Artificial Intelligence Market Research Report 2024

Artificial Intelligence AI in Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artificial Intelligence in Drug Discovery and Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Machine Learning in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global BYOD Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11T6229

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Translation Management Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36Z5964

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Archiving Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11S6221

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Point of Sale Automation System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11J6299

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions